Skip to Content

C1 Esterase Inhibitor, human

ATC (Anatomical Therapeutic Chemical Classification)


Therapeutic Categories

Hemostatic agent: Antifibrinolytic

Protease inhibitor

Treatment of hereditary angioedema

Chemical Name

C₁-inhibitor, human

Foreign Names

  • Humaner C1-Esterase-Inhibitor (German)
  • Inhibidor de C1 esterasa, humana (Spanish)

Generic Names

  • Complement C1 esterase inhibitor (IS)
  • UNII-6KIC4BB60G (IS)
  • Conestat Alfa (OS: BAN)
  • C1-INH (IS)
  • UNII-5QS67N4551 (IS)

Brand Names

  • Berinert
    CSL, Australia; CSL Behring, Austria; CSL Behring, Belgium; CSL Behring, Canada; CSL Behring, Switzerland; CSL Behring, Cyprus; CSL Behring, Germany; CSL Behring, Denmark; CSL Behring, Finland; CSL Behring, France; CSL Behring, Greece; CSL Behring, Hungary; CSL Behring, Israel; CSL Behring, Italy; CSL Behring, Norway; CSL Behring, Poland; CSL Behring, Sweden; CSL Behring UK, United Kingdom; P & D, Malta; ZLB Behring, Bulgaria
  • Berinert P
    CSL Behring, Spain
  • Cebitor
    Sanquin, Finland
  • Cetor
    Sanquin, Netherlands
  • Cinryze
    DRAC, Switzerland; Sanquin, Finland; Viropa, Italy; ViroPharma, Austria; ViroPharma, Belgium; ViroPharma, Germany; ViroPharma, Denmark; ViroPharma, France; ViroPharma, United Kingdom; ViroPharma, Iceland; ViroPharma, Lithuania; ViroPharma, Norway; ViroPharma, Poland; ViroPharma, Sweden
  • Ruconest
    Pharming, Portugal; Pharming Group, Hungary; Pharming Group, Latvia; Pharming Group, Norway; Pharming Group, Poland; Pharming Group, Romania; Pharming Group, Slovenia; Pharming Group N.V., Czech Republic; SOBI, Sweden; Swedish Orphan, Germany; Swedish Orphan, Denmark; Swedish Orphan, Italy; Swedish Orphan Biovitrum, Finland; Swedish Orphan Biovitrum, France; Swedish Orphan Biovitrum, United Kingdom; Pharming, Spain; Pharming Group, Austria; Pharming Group, Lithuania


BANBritish Approved Name
ISInofficial Synonym
OSOfficial Synonym

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.